
Summary
Rapid7 has 3 registry-verified rows in the CertReports index, last verified 17 Sep 2026. The strongest row is FedRAMP: FedRAMP Authorized. This page is independent of the vendor’s own trust centre: dates, sources and caveats come from CertReports captures.
Reviewer brief
As of 17 Sep 2026, Rapid7 is listed in the FedRAMP registry as FedRAMP Authorized, with authorization issued 11 Jul 2025 and audited by Schellman Compliance, LLC. As of 17 Sep 2026, Rapid7 is listed in the CSA STAR registry with a STAR Level 1 self-assessment (CAIQ) issued 27 May 2026. As of 17 Sep 2026, Rapid7 is listed in the EU-US Data Privacy Framework registry as Active for the UK Extension Certification, SW-US Certification, and EU-US Certification, with the current certification period expiring 2 Dec 2026. As of 17 Sep 2026, no public evidence found for SOC 2 for Rapid7. As of 17 Sep 2026, no public evidence found for HIPAA for Rapid7.
- FedRAMP: listed in FedRAMP registry as FedRAMP Authorized, issued 11 Jul 2025, audited by Schellman Compliance, LLC (as of 17 Sep 2026).
- CSA STAR: listed in CSA STAR registry, STAR Level 1 self-assessment (CAIQ), issued 27 May 2026 (as of 17 Sep 2026).
- EU-US Data Privacy Framework: listed in DPF registry as Active (UK Extension, SW-US, EU-US Certifications), current period expires 2 Dec 2026 (as of 17 Sep 2026).
Facts only, each dated; nothing here is inferred, scored or advised. Brief generated 17 Sep 2026; it is regenerated whenever a row changes.
Among security vendors
3verified rows
Category median 1, across 174 indexed security vendors. Rapid7 has more verified rows than 100 percent of them.
cybersecuritymanaged-servicesthreat-detectionvulnerability-management
Compare with similar vendors
Pick your own comparisonCompliance grid
Legal artefacts
No DPA, BAA or subprocessor list has been captured from a public page yet. Registry rows above do not depend on this.
Subprocessors
No subprocessor list captured yet.
Similar vendors with evidence
Related by product tags and the Security category, ranked by shared tags, description similarity and overlapping evidence. Never by popularity.